Ainos, Inc. Files 8-K on Financials

Ticker: AIMDW · Form: 8-K · Filed: May 12, 2025 · CIK: 1014763

Sentiment: neutral

Topics: financial-reporting, 8-K

Related Tickers: AIMD

TL;DR

Ainos (AIMD) filed an 8-K on May 12th detailing financial results and exhibits.

AI Summary

Ainos, Inc. filed an 8-K on May 12, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The company, formerly known as Amarillo Biosciences Inc., is incorporated in Texas and is involved in the pharmaceutical preparations industry.

Why It Matters

This filing provides investors with an update on Ainos, Inc.'s financial performance and condition, which is crucial for evaluating the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K filing?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported was on May 12, 2025.

What is the current business address of Ainos, Inc.?

The business address is 8880 Rio San Diego Drive, Ste. 800, San Diego, CA 92108.

What was Ainos, Inc. formerly known as?

Ainos, Inc. was formerly known as Amarillo Biosciences Inc.

In which state is Ainos, Inc. incorporated?

Ainos, Inc. is incorporated in Texas.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding Ainos, Inc. (AIMDW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing